Zhongwei Zhang   Izumi Tanaka   Rika Nakahashi-Ouchida   Peter B Ernst   Hiroshi Kiyono   Yosuke Kurashima   
Seminars in immunopathology 2024年1月 [査読有り]
Glycoprotein 2 (GP2) is a widely distributed protein in the digestive tract, contributing to mucosal barrier maintenance, immune homeostasis, and antigen-specific immune response, while also being linked to inflammatory bowel disease (IBD) pathoge...
BACKGROUND: Biologics are increasingly being used in patients with severe uncontrolled asthma. However, the trends in their use for treating severe asthma in Japan remain unclear. METHODS: The number of patients with asthma prescribed omalizumab o...
Respiratory syncytial virus (RSV) is a leading cause of upper and lower respiratory tract infection, especially in children and the elderly. Various vaccines containing the major transmembrane surface proteins of RSV (proteins F and G) have been t...
Trends in molecular medicine 29(2) 124-140 2023年2月 [査読有り]
Nasal vaccines induce pathogen-specific dual protective immunity at mucosal surfaces and systemically throughout the body. Consequently, nasal vaccines both prevent pathogen invasion and reduce disease severity. Because of these features, nasal va...
Ogata H   Narentonglega   Tanaka I   Matsukura F   Morimoto M   Kiyono H   Nakano T   Hamada H   Kurashima Y   
Dr. Toshinori Nakayama Memorial cMAV-cSIMVa Workshop 2024年1月20日
Zhang Z   Shimada K   Saito Y   Ernst BP   Matsumoto Y   Ohira G   Matsubara H   Kiyono H   Kurashima Y   
Dr. Toshinori Nakayama Memorial cMAV-cSIMVa Workshop 2024年1月20日
Sasa H   Saito S   Wu Y   Zhang Z   Murasaki S   He J   Narentonglega   Kiyono H   Kurashima Y   
Dr. Toshinori Nakayama Memorial cMAV-cSIMVa Workshop 2024年1月20日